Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
China Medical System HoldingsCHSYF +0.11%87 PB Ratio is 1.55 as of Jul. 30, 2026, which is 24% below its 10-year median of 2.03. GuruFocus rates CHSYF with a GF Score™ of 87/100 and a GF Value™ of $1.30 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 921 Drug Manufacturers companies, China Medical System Holdings ranks better than 58.41% on this metric.
The historical rank and industry rank for China Medical System Holdings's PB Ratio or its related term are showing as below:
CHSYF'
s PB Ratio Range Over the Past 10 Years
Min: 0.93 Med: 2.03 Max: 6.51
Current: 1.53
During the past 13 years, China Medical System Holdings's highest PB Ratio was 6.51. The lowest was 0.93. And the median was 2.03.
CHSYF's PB Ratio is ranked better than 58.41% of 921
companies
in the Drug Manufacturers industry
Industry Median: 1.86
vs CHSYF: 1.53
During the past 12 months, China Medical System Holdings's average Book Value Per Share Growth Rate was 10.40% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 5.80% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 7.00% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 12.50% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of China Medical System Holdings was 85.00% per year. The lowest was 4.00% per year. And the median was 18.40% per year.
Back to Basics: PB Ratio
China Medical System Holdings (OTCPK:CHSYF) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
China Medical System Holdings PB Ratio Related Terms
China Medical System Holdings PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, China Medical System Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Medical System Holdings PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, China Medical System Holdings's PB Ratio distribution charts can be found below:
* The bar in red indicates where China Medical System Holdings's PB Ratio falls into.
China Medical System Holdings PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
China Medical System Holdings (CHSYF) has a PB Ratio of 1.55 as of Jul. 30, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on China Medical System Holdings and its competitors. This is 24% below median its historical median of 2.03. Over the past decade, China Medical System Holdings' PB Ratio has ranged from 0.93 to 6.51. According to the industry distribution chart, China Medical System Holdings ranks #383 out of 921 companies in the Drug Manufacturers industry, placing it in the top 41.6%.
Is China Medical System Holdings' PB Ratio too high?
China Medical System Holdings' current PB Ratio of 1.55 is 24% below median its 10-year median of 2.03. Over the past 10 years, this metric has ranged from a low of 0.93 to a high of 6.51. The Drug Manufacturers industry median PB Ratio is 1.86. China Medical System Holdings' value of 1.55 is 16.7% below this industry median. Based on the distribution chart, China Medical System Holdings ranks #383 out of 921 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, China Medical System Holdings has a GF Score™ of 87/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does China Medical System Holdings' PB Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, China Medical System Holdings ranks #383 out of 921 companies for PB Ratio. This puts China Medical System Holdings in the upper half of its industry. The industry median PB Ratio is 1.86. China Medical System Holdings' value of 1.55 is 16.7% below this benchmark. Historically, China Medical System Holdings' own PB Ratio has ranged from 0.93 to 6.51 over the past decade. While the company's 10-year median is 2.03 vs. the industry median of 1.86, China Medical System Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.86, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Medical System Holdings's current PB Ratio of 1.55 is 16.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on China Medical System Holdings and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Medical System Holdings's current PB Ratio is 1.55, which is 24% below median its own 10-year median of 2.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Medical System Holdings stock overvalued right now?
Based on GuruFocus' analysis, China Medical System Holdings (CHSYF) is currently considered Modestly Overvalued. The stock's GF Value™ is $1.30, compared to a current price of $1.57 — trading 20.8% above its estimated fair value. The current PB Ratio is 1.55, which is 24% below median its 10-year median of 2.03 and 16.7% below the Drug Manufacturers industry median of 1.86. China Medical System Holdings' overall GF Score™ is 87/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For China Medical System Holdings (CHSYF), the current PB Ratio is 1.55 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Medical System Holdings (CHSYF) Overvalued in 2026?
Based on GuruFocus' analysis, China Medical System Holdings stock appears to be overvalued.
The current stock price of $1.57 is trading 20.8% above its estimated GF Value™ of $1.30.
GuruFocus considers China Medical System Holdings to be Modestly Overvalued.
Key valuation signals for CHSYF:
PB Ratio: 1.55 (24% below median its 10-year median of 2.03)
GF Value™: $1.30 vs. price of $1.57 (20.8% above fair value)
Industry Position: 16.7% below the Drug Manufacturers median (#383 of 921)
No single metric tells the full story. See the CHSYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Medical System Holdings Business Description
China Medical System Holdings Ltd is a holding company. Along with its subsidiaries, it is engaged in the research and development, production, promotion and sale of medicines. The company's reportable segments are: (i) Integrated pharmaceuticals portfolio and (ii) Skin diseases related business. The majority of the company's revenue, which consists of pharmaceutical products sales, is derived from the integrated pharmaceuticals portfolio segment.
87GF Score
Get the complete analysis for CHSYF
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHSYF has been successfully added to your 
